Global RNAi for Therapeutic Market Growth (Status and Outlook) 2019-2024

Publisher Name :
Date: 01-Nov-2019
No. of pages: 132

According to this study, over the next five years the RNAi for Therapeutic market will register a 24.0% CAGR in terms of revenue, the global market size will reach US$ 2802.7 million by 2024, from US$ 1186.9 million in 2019. In particular, this report presents the global revenue market share of key companies in RNAi for Therapeutic business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of RNAi for Therapeutic market by product type, application, key companies and key regions.

This study considers the RNAi for Therapeutic value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.

- siRNA

- miRNA

- shRNA

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.

- Cancer

- Cardiovascular

- HBV

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Spain

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Alnylam Pharmaceuticals

- miRagen Therapeutics

- Arbutus Biopharma (Tekmira)

- Dicerna Pharmaceuticals

- Mirna Therapeutics

- Arrowhead

- Silence Therapeutics

- Quark Pharmaceuticals

- Benitec Biopharma

- RXi Pharmaceuticals

- Sylentis

- Silenseed

- Sirnaomics

- Gradalis

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global RNAi for Therapeutic market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

- To understand the structure of RNAi for Therapeutic market by identifying its various subsegments.

- Focuses on the key global RNAi for Therapeutic players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the RNAi for Therapeutic with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of RNAi for Therapeutic submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global RNAi for Therapeutic Market Growth (Status and Outlook) 2019-2024

Table of Contents

Global RNAi for Therapeutic Market Growth (Status and Outlook) 2019-2024

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global RNAi for Therapeutic Market Size 2014-2024
2.1.2 RNAi for Therapeutic Market Size CAGR by Region
2.2 RNAi for Therapeutic Segment by Type
2.2.1 siRNA
2.2.2 siRNA
2.2.3 shRNA
2.3 RNAi for Therapeutic Market Size by Type
2.3.1 Global RNAi for Therapeutic Market Size Market Share by Type (2014-2019)
2.3.2 Global RNAi for Therapeutic Market Size Growth Rate by Type (2014-2019)
2.4 RNAi for Therapeutic Segment by Application
2.4.1 Cancer
2.4.2 Cardiovascular
2.4.3 HBV
2.4.4 Other
2.5 RNAi for Therapeutic Market Size by Application
2.5.1 Global RNAi for Therapeutic Market Size Market Share by Application (2014-2019)
2.5.2 Global RNAi for Therapeutic Market Size Growth Rate by Application (2014-2019)

3 Global RNAi for Therapeutic by Players
3.1 Global RNAi for Therapeutic Market Size Market Share by Players
3.1.1 Global RNAi for Therapeutic Market Size by Players (2017-2019)
3.1.2 Global RNAi for Therapeutic Market Size Market Share by Players (2017-2019)
3.2 Global RNAi for Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RNAi for Therapeutic by Regions
4.1 RNAi for Therapeutic Market Size by Regions
4.2 Americas RNAi for Therapeutic Market Size Growth
4.3 APAC RNAi for Therapeutic Market Size Growth
4.4 Europe RNAi for Therapeutic Market Size Growth
4.5 Middle East & Africa RNAi for Therapeutic Market Size Growth

5 Americas
5.1 Americas RNAi for Therapeutic Market Size by Countries
5.2 Americas RNAi for Therapeutic Market Size by Type
5.3 Americas RNAi for Therapeutic Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC RNAi for Therapeutic Market Size by Countries
6.2 APAC RNAi for Therapeutic Market Size by Type
6.3 APAC RNAi for Therapeutic Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe RNAi for Therapeutic by Countries
7.2 Europe RNAi for Therapeutic Market Size by Type
7.3 Europe RNAi for Therapeutic Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa RNAi for Therapeutic by Countries
8.2 Middle East & Africa RNAi for Therapeutic Market Size by Type
8.3 Middle East & Africa RNAi for Therapeutic Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global RNAi for Therapeutic Market Forecast
10.1 Global RNAi for Therapeutic Market Size Forecast (2019-2024)
10.2 Global RNAi for Therapeutic Forecast by Regions
10.2.1 Global RNAi for Therapeutic Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global RNAi for Therapeutic Forecast by Type
10.8 Global RNAi for Therapeutic Forecast by Application

11 Key Players Analysis
11.1 Alnylam Pharmaceuticals
11.1.1 Company Details
11.1.2 RNAi for Therapeutic Product Offered
11.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Alnylam Pharmaceuticals News
11.2 miRagen Therapeutics
11.2.1 Company Details
11.2.2 RNAi for Therapeutic Product Offered
11.2.3 miRagen Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 miRagen Therapeutics News
11.3 Arbutus Biopharma (Tekmira)
11.3.1 Company Details
11.3.2 RNAi for Therapeutic Product Offered
11.3.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Arbutus Biopharma (Tekmira) News
11.4 Dicerna Pharmaceuticals
11.4.1 Company Details
11.4.2 RNAi for Therapeutic Product Offered
11.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Dicerna Pharmaceuticals News
11.5 Mirna Therapeutics
11.5.1 Company Details
11.5.2 RNAi for Therapeutic Product Offered
11.5.3 Mirna Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Mirna Therapeutics News
11.6 Arrowhead
11.6.1 Company Details
11.6.2 RNAi for Therapeutic Product Offered
11.6.3 Arrowhead RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Arrowhead News
11.7 Silence Therapeutics
11.7.1 Company Details
11.7.2 RNAi for Therapeutic Product Offered
11.7.3 Silence Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Silence Therapeutics News
11.8 Quark Pharmaceuticals
11.8.1 Company Details
11.8.2 RNAi for Therapeutic Product Offered
11.8.3 Quark Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Quark Pharmaceuticals News
11.9 Benitec Biopharma
11.9.1 Company Details
11.9.2 RNAi for Therapeutic Product Offered
11.9.3 Benitec Biopharma RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Benitec Biopharma News
11.10 RXi Pharmaceuticals
11.10.1 Company Details
11.10.2 RNAi for Therapeutic Product Offered
11.10.3 RXi Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 RXi Pharmaceuticals News
11.11 Sylentis
11.12 Silenseed
11.13 Sirnaomics
11.14 Gradalis

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of RNAi for Therapeutic
Figure RNAi for Therapeutic Report Years Considered
Figure Market Research Methodology
Figure Global RNAi for Therapeutic Market Size Growth Rate 2014-2024 ($ Millions)
Table RNAi for Therapeutic Market Size CAGR by Region 2014-2024 ($ Millions)
Table Major Players of siRNA
Table Major Players of miRNA
Table Major Players of shRNA
Table Market Size by Type (2014-2019) ($ Millions)
Table Global RNAi for Therapeutic Market Size Market Share by Type (2014-2019)
Figure Global RNAi for Therapeutic Market Size Market Share by Type (2014-2019)
Figure Global siRNA Market Size Growth Rate
Figure Global miRNA Market Size Growth Rate
Figure Global shRNA Market Size Growth Rate
Figure RNAi for Therapeutic Consume????!D in Cancer
Figure Global RNAi for Therapeutic Market: Cancer (2014-2019) ($ Millions)
Figure Global Cancer YoY Growth ($ Millions)
Figure RNAi for Therapeutic Consume????!D in Cardiovascular
Figure Global RNAi for Therapeutic Market: Cardiovascular (2014-2019) ($ Millions)
Figure Global Cardiovascular YoY Growth ($ Millions)
Figure RNAi for Therapeutic Consume????!D in HBV
Figure Global RNAi for Therapeutic Market: HBV (2014-2019) ($ Millions)
Figure Global HBV YoY Growth ($ Millions)
Figure RNAi for Therapeutic Consume????!D in Other
Figure Global RNAi for Therapeutic Market: Other (2014-2019) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global RNAi for Therapeutic Market Size by Application (2014-2019) ($ Millions)
Table Global RNAi for Therapeutic Market Size Market Share by Application (2014-2019)
Figure Global RNAi for Therapeutic Market Size Market Share by Application (2014-2019)
Figure Global RNAi for Therapeutic Market Size in Cancer Growth Rate
Figure Global RNAi for Therapeutic Market Size in Cardiovascular Growth Rate
Figure Global RNAi for Therapeutic Market Size in HBV Growth Rate
Figure Global RNAi for Therapeutic Market Size in Other Growth Rate
Table Global RNAi for Therapeutic Revenue by Players (2017-2019) ($ Millions)
Table Global RNAi for Therapeutic Revenue Market Share by Players (2017-2019)
Figure Global RNAi for Therapeutic Revenue Market Share by Players in 2018
Table Global RNAi for Therapeutic Key Players Head office and Products Offered
Table RNAi for Therapeutic Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global RNAi for Therapeutic Market Size by Regions 2014-2019 ($ Millions)
Table Global RNAi for Therapeutic Market Size Market Share by Regions 2014-2019
Figure Global RNAi for Therapeutic Market Size Market Share by Regions 2014-2019
Figure Americas RNAi for Therapeutic Market Size 2014-2019 ($ Millions)
Figure APAC RNAi for Therapeutic Market Size 2014-2019 ($ Millions)
Figure Europe RNAi for Therapeutic Market Size 2014-2019 ($ Millions)
Figure Middle East & Africa RNAi for Therapeutic Market Size 2014-2019 ($ Millions)
Table Americas RNAi for Therapeutic Market Size by Countries (2014-2019) ($ Millions)
Table Americas RNAi for Therapeutic Market Size Market Share by Countries (2014-2019)
Figure Americas RNAi for Therapeutic Market Size Market Share by Countries in 2018
Table Americas RNAi for Therapeutic Market Size by Type (2014-2019) ($ Millions)
Table Americas RNAi for Therapeutic Market Size Market Share by Type (2014-2019)
Figure Americas RNAi for Therapeutic Market Size Market Share by Type in 2018
Table Americas RNAi for Therapeutic Market Size by Application (2014-2019) ($ Millions)
Table Americas RNAi for Therapeutic Market Size Market Share by Application (2014-2019)
Figure Americas RNAi for Therapeutic Market Size Market Share by Application in 2018
Figure United States RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure Canada RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure Mexico RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Table APAC RNAi for Therapeutic Market Size by Countries (2014-2019) ($ Millions)
Table APAC RNAi for Therapeutic Market Size Market Share by Countries (2014-2019)
Figure APAC RNAi for Therapeutic Market Size Market Share by Countries in 2018
Table APAC RNAi for Therapeutic Market Size by Type (2014-2019) ($ Millions)
Table APAC RNAi for Therapeutic Market Size Market Share by Type (2014-2019)
Figure APAC RNAi for Therapeutic Market Size Market Share by Type in 2018
Table APAC RNAi for Therapeutic Market Size by Application (2014-2019) ($ Millions)
Table APAC RNAi for Therapeutic Market Size Market Share by Application (2014-2019)
Figure APAC RNAi for Therapeutic Market Size Market Share by Application in 2018
Figure China RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure Japan RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure Korea RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure Southeast Asia RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure India RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure Australia RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Table Europe RNAi for Therapeutic Market Size by Countries (2014-2019) ($ Millions)
Table Europe RNAi for Therapeutic Market Size Market Share by Countries (2014-2019)
Figure Europe RNAi for Therapeutic Market Size Market Share by Countries in 2018
Table Europe RNAi for Therapeutic Market Size by Type (2014-2019) ($ Millions)
Table Europe RNAi for Therapeutic Market Size Market Share by Type (2014-2019)
Figure Europe RNAi for Therapeutic Market Size Market Share by Type in 2018
Table Europe RNAi for Therapeutic Market Size by Application (2014-2019) ($ Millions)
Table Europe RNAi for Therapeutic Market Size Market Share by Application (2014-2019)
Figure Europe RNAi for Therapeutic Market Size Market Share by Application in 2018
Figure Germany RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure France RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure UK RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure Italy RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure Russia RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure Spain RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Table Middle East & Africa RNAi for Therapeutic Market Size by Countries (2014-2019) ($ Millions)
Table Middle East & Africa RNAi for Therapeutic Market Size Market Share by Countries (2014-2019)
Figure Middle East & Africa RNAi for Therapeutic Market Size Market Share by Countries in 2018
Table Middle East & Africa RNAi for Therapeutic Market Size by Type (2014-2019) ($ Millions)
Table Middle East & Africa RNAi for Therapeutic Market Size Market Share by Type (2014-2019)
Figure Middle East & Africa RNAi for Therapeutic Market Size Market Share by Type in 2018
Table Middle East & Africa RNAi for Therapeutic Market Size by Application (2014-2019) ($ Millions)
Table Middle East & Africa RNAi for Therapeutic Market Size Market Share by Application (2014-2019)
Figure Middle East & Africa RNAi for Therapeutic Market Size Market Share by Application in 2018
Figure Egypt RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure South Africa RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure Israel RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure Turkey RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure GCC Countries RNAi for Therapeutic Market Size Growth 2014-2019 ($ Millions)
Figure Global RNAi for Therapeutic arket Size Forecast (2019-2024) ($ Millions)
Table Global RNAi for Therapeutic Market Size Forecast by Regions (2019-2024) ($ Millions)
Table Global RNAi for Therapeutic Market Size Market Share Forecast by Regions
Figure Americas RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure APAC RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Europe RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Middle East & Africa RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure United States RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Canada RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Mexico RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Brazil RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure China RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Japan RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Korea RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Southeast Asia RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure India RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Australia RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Germany RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure France RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure UK RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Italy RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Russia RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Spain RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Egypt RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure South Africa RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Israel RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure Turkey RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Figure GCC Countries RNAi for Therapeutic Market Size 2019-2024 ($ Millions)
Table Global RNAi for Therapeutic Market Size Forecast by Type (2019-2024) ($ Millions)
Table Global RNAi for Therapeutic Market Size Market Share Forecast by Type (2019-2024)
Table Global RNAi for Therapeutic Market Size Forecast by Application (2019-2024) ($ Millions)
Table Global RNAi for Therapeutic Market Size Market Share Forecast by Application (2019-2024)
Table Alnylam Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Alnylam Pharmaceuticals RNAi for Therapeutic Revenue and Gross Margin (2017-2019)
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Market Share (2017-2019)
Table miRagen Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table miRagen Therapeutics RNAi for Therapeutic Revenue and Gross Margin (2017-2019)
Figure miRagen Therapeutics RNAi for Therapeutic Market Share (2017-2019)
Table Arbutus Biopharma (Tekmira) Basic Information, Head Office, Major Market Areas and Its Competitors
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue and Gross Margin (2017-2019)
Figure Arbutus Biopharma (Tekmira) RNAi for Therapeutic Market Share (2017-2019)
Table Dicerna Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Dicerna Pharmaceuticals RNAi for Therapeutic Revenue and Gross Margin (2017-2019)
Figure Dicerna Pharmaceuticals RNAi for Therapeutic Market Share (2017-2019)
Table Mirna Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Mirna Therapeutics RNAi for Therapeutic Revenue and Gross Margin (2017-2019)
Figure Mirna Therapeutics RNAi for Therapeutic Market Share (2017-2019)
Table Arrowhead Basic Information, Head Office, Major Market Areas and Its Competitors
Table Arrowhead RNAi for Therapeutic Revenue and Gross Margin (2017-2019)
Figure Arrowhead RNAi for Therapeutic Market Share (2017-2019)
Table Silence Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Silence Therapeutics RNAi for Therapeutic Revenue and Gross Margin (2017-2019)
Figure Silence Therapeutics RNAi for Therapeutic Market Share (2017-2019)
Table Quark Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Quark Pharmaceuticals RNAi for Therapeutic Revenue and Gross Margin (2017-2019)
Figure Quark Pharmaceuticals RNAi for Therapeutic Market Share (2017-2019)
Table Benitec Biopharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Benitec Biopharma RNAi for Therapeutic Revenue and Gross Margin (2017-2019)
Figure Benitec Biopharma RNAi for Therapeutic Market Share (2017-2019)
Table RXi Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table RXi Pharmaceuticals RNAi for Therapeutic Revenue and Gross Margin (2017-2019)
Figure RXi Pharmaceuticals RNAi for Therapeutic Market Share (2017-2019)
Table Sylentis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Silenseed Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sirnaomics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Gradalis Basic Information, Head Office, Major Market Areas and Its Competitors
  • Global RNAi for Therapeutic Market Research Report 2015-2025
    Published: 25-Feb-2020        Price: US 1800 Onwards        Pages: 82
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • Global Antisense and RNAi Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    Published: 24-Feb-2020        Price: US 3480 Onwards        Pages: 103
    Market Overview The global Antisense and RNAi Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antisense and RNAi Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive......
  • Global Targeted RNA Sequencing Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 23-Feb-2020        Price: US 2980 Onwards        Pages: 84
    Snapshot The global Targeted RNA Sequencing market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Targeted RNA Sequencing by product, region and application, in addition, this report introduces market competition situation among the vendors ......
  • Global RNAi for Therapeutic Market Data Survey Report 2015-2025
    Published: 11-Feb-2020        Price: US 1500 Onwards        Pages: 61
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • RNAi Therapeutics Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 147
    RNAi Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global RNAi Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the RNAi Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese RNAi Therape......
  • RNAi for Therapeutic Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 148
    RNAi for Therapeutic Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global RNAi for Therapeutic industry with a focus on the Chinese market. The report provides key statistics on the market status of the RNAi for Therapeutic manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese RNA......
  • Antisense and RNAI Therapeutics Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 06-Feb-2020        Price: US 3000 Onwards        Pages: 143
    Antisense and RNAi Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Antisense and RNAi Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Antisense and RNAi Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of ......
  • 2020-2025 Global and Regional RNAi for Therapeutic Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report
    Published: 05-Feb-2020        Price: US 3500 Onwards        Pages: 165
    HNY Research projects that the RNAi for Therapeutic market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Alnylam Pharmaceuticals, Silence Therapeutics, Dicerna Pharmaceuticals, Arbutus Biopharma (Tekmira), RXi Pharmaceuticals, Arrowhead, miRagen Therapeutics, Quark Pharmaceuticals, Mirna Therapeutics, Benitec Biopharma, Sylenti......
  • Global RNAi for Therapeutic Market Growth (Status and Outlook) 2020-2025
    Published: 21-Jan-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the RNAi for Therapeutic market will register a 24.0% CAGR in terms of revenue, the global market size will reach $ 3515.2 million by 2025, from $ 1488.6 million in 2019. In particular, this report presents the global revenue market share of key companies in RNAi for Therapeutic business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of RNAi for Therapeutic market by type......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs